The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industries.
As a full-service provider, Aenova develops, produces and packages all common dosage forms, product groups and active ingredient classes of pharmaceuticals and food supplements for human and animal health: solid, semi-solid and liquid, sterile and non-sterile, high and low dose, OEB 1-5, and fill&finish of biologics/vaccines up to BSL-2.
With many years of experience and know-how also in innovative technologies, Aenova supports its customers in the realization of new drug products from development to commercial manufacturing, including break through therapies.
Around 4,200 employees at 15 production sites worldwide contribute to Aenova's success.
For more information see www.aenova-group.com